Martin Poirier

发表

A Blender Plugin for Collaborative Work on the Articiel Platform

Omar Cherkaoui, Faisal Abouzaid, Gilles Raîche, 2007, Software Engineering Research and Practice.

Blender plugin implementations for 3D collaborative work

Omar Cherkaoui, Faisal Abouzaid, Martin Riopel, 2007, 2007 IEEE International Conference on Systems, Man and Cybernetics.

Rig retargeting for 3D animation

Eric Paquette, Martin Poirier, Eric Paquette, 2009, Graphics Interface.

Analyse préliminaire dans le cadre de l'étude pour le développement et l'exploitation d'outils et de services collectifs d'une bibliothèque de recherche virtuelle québécoise

Martin Poirier, 2002 .

Methods for fast skeleton sketching

Eric Paquette, Martin Poirier, 2009, SIGGRAPH '09.

Synthesis of BILN 2061, an HCV NS3 protease inhibitor with proven antiviral effect in humans.

Martin Poirier, C. Brochu, M. Poirier, 2004, Organic letters.

NMR structural characterization of peptide inhibitors bound to the Hepatitis C virus NS3 protease: design of a new P2 substituent.

Martin Poirier, P. Bonneau, D. Lamarre, 2004, Journal of medicinal chemistry.

Peptide-based inhibitors of the hepatitis C virus NS3 protease: structure-activity relationship at the C-terminal position.

Martin Poirier, D. Lamarre, M. Poirier, 2004, Journal of medicinal chemistry.

Indole 5-carboxamide Thumb Pocket I inhibitors of HCV NS5B polymerase with nanomolar potency in cell-based subgenomic replicons (part 2): central amino acid linker and right-hand-side SAR studies.

Martin Poirier, J. Duan, M. Garneau, 2011, Bioorganic & medicinal chemistry letters.

Importance of ligand bioactive conformation in the discovery of potent indole-diamide inhibitors of the hepatitis C virus NS5B.

Araz Jakalian, Martin Poirier, C. Brochu, 2010, Journal of the American Chemical Society.

Structure-based design of novel HCV NS5B thumb pocket 2 allosteric inhibitors with submicromolar gt1 replicon potency: discovery of a quinazolinone chemotype.

Araz Jakalian, Martin Poirier, Cédrickx Godbout, 2013, Bioorganic & medicinal chemistry letters.

Structure-activity study on a novel series of macrocyclic inhibitors of the hepatitis C virus NS3 protease leading to the discovery of BILN 2061.

Martin Poirier, M. Garneau, D. Lamarre, 2004, Journal of medicinal chemistry.